<!DOCTYPE html>
<html lang="it">
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        
        
        <link rel="canonical" href="https://postssrisyndrome.github.io/postssrisyndrome/news/newsletter-2022-09-01/">
        <link rel="shortcut icon" href="../../img/favicon.ico">
        <title>Newsletter 2022-09-01 - Post-SSRI Syndrome</title>
        <link href="../../css/bootstrap.min.css" rel="stylesheet">
        <link href="../../css/font-awesome.min.css" rel="stylesheet">
        <link href="../../css/base.css" rel="stylesheet">
        <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.5.0/styles/github.min.css">
        <link href="../../css/extra.css" rel="stylesheet">

        <script src="../../js/jquery-1.10.2.min.js" defer></script>
        <script src="../../js/bootstrap.min.js" defer></script>
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.5.0/highlight.min.js"></script>
        <script>hljs.initHighlightingOnLoad();</script> 
    </head>

    <body>
        <div class="navbar fixed-top navbar-expand-lg navbar-dark bg-primary">
            <div class="container">
                <a class="navbar-brand" href="../..">Post-SSRI Syndrome</a>
                <!-- Expander button -->
                <button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#navbar-collapse">
                    <span class="navbar-toggler-icon"></span>
                </button>

                <!-- Expanded navigation -->
                <div id="navbar-collapse" class="navbar-collapse collapse">
                        <!-- Main navigation -->
                        <ul class="nav navbar-nav">
                            <li class="navitem">
                                <a href="../" class="nav-link">News</a>
                            </li>
                            <li class="dropdown">
                                <a href="#" class="nav-link dropdown-toggle" data-toggle="dropdown">La sindrome <b class="caret"></b></a>
                                <ul class="dropdown-menu">
                                    
<li>
    <a href="../../la-sindrome/caratteristiche/" class="dropdown-item">Caratteristiche</a>
</li>
                                    
<li>
    <a href="../../la-sindrome/prevalenza/" class="dropdown-item">Quanto Ã¨ comune?</a>
</li>
                                    
<li>
    <a href="../../la-sindrome/farmaci/" class="dropdown-item">Farmaci coinvolti</a>
</li>
                                    
<li>
    <a href="../../la-sindrome/faq/" class="dropdown-item">Domande frequenti</a>
</li>
                                    
<li>
    <a href="../../la-sindrome/criteri-diagnostici/" class="dropdown-item">Criteri diagnostici</a>
</li>
                                    
<li>
    <a href="../../la-sindrome/storie/" class="dropdown-item">Esperienze dei pazienti</a>
</li>
                                </ul>
                            </li>
                            <li class="dropdown">
                                <a href="#" class="nav-link dropdown-toggle" data-toggle="dropdown">Ricerca <b class="caret"></b></a>
                                <ul class="dropdown-menu">
                                    
<li>
    <a href="../../ricerca/bibliografia/" class="dropdown-item">Bibliografia</a>
</li>
                                    
<li>
    <a href="../../ricerca/ricerca-in-corso/" class="dropdown-item">Ricerca in corso</a>
</li>
                                    
<li>
    <a href="https://www.gofundme.com/f/27l8qmes5c" class="dropdown-item">Aiutare la ricerca</a>
</li>
                                </ul>
                            </li>
                            <li class="dropdown">
                                <a href="#" class="nav-link dropdown-toggle" data-toggle="dropdown">Media <b class="caret"></b></a>
                                <ul class="dropdown-menu">
                                    
<li>
    <a href="../../media/medici/" class="dropdown-item">Divulgazione medica</a>
</li>
                                    
<li>
    <a href="../../media/articoli/" class="dropdown-item">Stampa e media digitali</a>
</li>
                                    
<li>
    <a href="../../media/video/" class="dropdown-item">Video</a>
</li>
                                </ul>
                            </li>
                            <li class="dropdown">
                                <a href="#" class="nav-link dropdown-toggle" data-toggle="dropdown">Risorse <b class="caret"></b></a>
                                <ul class="dropdown-menu">
                                    
<li>
    <a href="../../risorse/organismi/" class="dropdown-item">Organismi</a>
</li>
                                    
<li>
    <a href="https://www.pssdforum.org" class="dropdown-item">Forum</a>
</li>
                                    
<li>
    <a href="../../risorse/links/" class="dropdown-item">Link utili</a>
</li>
                                </ul>
                            </li>
                            <li class="navitem">
                                <a href="https://www.gofundme.com/f/27l8qmes5c" class="nav-link">Donazioni</a>
                            </li>
                        </ul>

                    <ul class="nav navbar-nav ml-auto">
                        <li class="nav-item">
                            <a href="#" class="nav-link" data-toggle="modal" data-target="#mkdocs_search_modal">
                                <i class="fa fa-search"></i> Cerca
                            </a>
                        </li>
                    </ul>
                </div>
            </div>
        </div>

        <div class="container">
            <div class="row">
                    <div class="col-md-3"><div class="navbar-light navbar-expand-md bs-sidebar hidden-print affix" role="complementary">
    <div class="navbar-header">
        <button type="button" class="navbar-toggler collapsed" data-toggle="collapse" data-target="#toc-collapse" title="Tabella dei Contenuti">
            <span class="fa fa-angle-down"></span>
        </button>
    </div>

    
    <div id="toc-collapse" class="navbar-collapse collapse card bg-secondary">
        <ul class="nav flex-column">
            
            <li class="nav-item" data-level="1"><a href="#newsletter-2022-09-01" class="nav-link">Newsletter 2022-09-01</a>
              <ul class="nav flex-column">
            <li class="nav-item" data-level="2"><a href="#common-molecular-target-found-between-paroxetine-and-finasteride-that-could-explain-sexual-dysfunction" class="nav-link">Common molecular target found between paroxetine and finasteride that could explain sexual dysfunction</a>
              <ul class="nav flex-column">
              </ul>
            </li>
            <li class="nav-item" data-level="2"><a href="#trovato-un-target-molecolare-in-comune-tra-paroxetina-e-finasteride-che-potrebbe-spiegare-le-disfunzioni-sessuali" class="nav-link">Trovato un target molecolare in comune tra paroxetina e finasteride che potrebbe spiegare le disfunzioni sessuali</a>
              <ul class="nav flex-column">
              </ul>
            </li>
              </ul>
            </li>
        </ul>
    </div>
</div></div>
                    <div class="col-md-9" role="main">

<h1 id="newsletter-2022-09-01">Newsletter 2022-09-01</h1>
<h2 id="common-molecular-target-found-between-paroxetine-and-finasteride-that-could-explain-sexual-dysfunction">Common molecular target found between paroxetine and finasteride that could explain sexual dysfunction</h2>
<p>Paroxetine also inhibits PNMT, the enzyme responsible for adrenaline synthesis.</p>
<p>This multidisciplinary work by the research unit coordinated by Prof. R.C. Melcangi of the University of Milan on SSRIs has been published in the Journal of Molecular Structure. Shareable link with free access and download to the full text until Sept. 2: https://authors.elsevier.com/c/1fQ7v_WRZ2kK1).</p>
<p>How was it possible to find a new off-target of paroxetine for the first time in a full 30 years after its commercialization?</p>
<p>A multidisciplinary approach was used. The first step involved an innovative computational method, developed by an Italian researcher in Milan, that can search the entire human structural proteome (tens of thousands of proteins) for potential binding sites of the drug under study, in this case paroxetine.</p>
<p>Importantly, this in silico screening was not intended to find targets in common with finasteride, but all proteins (off-target, i.e., other than the serotonin transporter) that could bind to paroxetine for purely structural reasons.</p>
<p>Among the potential binding sites returned by the software, among the most likely ones (based on their three-dimensional structure) was found to be phenylethanolamine N-methyltransferase (PNMT), the enzyme that converts norepinephrine to adrenaline (the last step in catecholamine biosynthesis), which is involved in several biological processes, including erection.</p>
<p>At this point, of course, the thing that struck the researchers was that the same off-target had previously been found (by the same researchers: Giatti, Silvia, et al. "Three-dimensional proteome-wide scale screening for the 5-alpha reductase inhibitor finasteride: identification of a novel off-target." Journal of medicinal chemistry 64.8 (2021): 4553-4566) for finasteride, a drug associated with sexual dysfunction, both during, and after discontinuation of the drug, (as the package inserts now report). So it was decided to investigate further and test whether indeed paroxetine also interacts with the PNMT enzyme, as the computational agnostic screening had suggested.</p>
<p>Further in silico analysis, in this case docking and molecular dynamics, indeed confirmed the result of the computational screening, in the sense that the drug-protein interaction indeed seemed to be able to take place without problems, moreover at the same catalytic site where norepinephrine is positioned to be methylated and form adrenaline. This suggests competitive inhibition.</p>
<p>After that, experimental assays were performed, first in vitro, and then in vivo: the in vitro assay actually found a partial inhibition of the PNMT enzyme, while the in vivo assay measured a reduced level of adrenaline (the product of PNMT, precisely) in the adrenal gland.</p>
<p>Both in vitro and in vivo experiments thus confirmed and validated the result of the computational screening, namely, a partial inhibition of the PNMT enzyme by paroxetine.</p>
<p>Since adrenaline intervenes in the mechanism of erection, antagonizing noradrenaline, these results suggest that paroxetine-induced sexual dysfunction may be due, at least in part, to PNMT inhibition. It should also be kept in mind that not everyone has the same expression levels of the enzyme, so for some, even partial inhibition of it could have very serious effects.</p>
<p>Further studies are needed to confirm that this inhibition is indeed a cause or concomitant cause of erectile dysfunction and to explore other potential mechanisms by which SSRI antidepressants might induce sexual side effects, both while taking the drug and after its discontinuation.</p>
<p>It is not discussed in the paper, but this inhibition could also help explain other effects (emotional, cognitive, ...?) of paroxetine, since adrenaline intervenes in various biological processes.</p>
<p>This finding is important not only because it finds a new unexpected off-target never before found that could explain sexual dysfunction, but also because it confirms that there are mechanisms in common between SSRIs and finasteride, as researchers had previously hypothesized, since finasteride and paroxetine share a same enzyme target (PNMT). This is an unexpected element that brings PSSD closer to PFS.</p>
<p>"It is interesting to note that different molecules (i.e., paroxetine and finasteride), with different chemical structures (i.e., a lipophilic base amine and an azasteroid), but producing a similar end-point phenotype (e.g., sexual dysfunction), are supposed to interact with the same enzymatic target, such as PNMT."</p>
<p>To cite the paper:
Giatti, Silvia, et al. "Identification of a novel off-target of paroxetine: Possible role in sexual dysfunction induced by this SSRI antidepressant drug." Journal of Molecular Structure 1268 (2022): 133690</p>
<p>More study from the University of Milan:</p>
<p>âResults obtained reveal that paroxetine significantly affects steroid levels, only in the colon but not in plasma. In particular, steroid modifications observed immediately after treatment are not overlap with those detected at withdrawal. Additionally, paroxetine treatment and its withdrawal impact gut microbiota populations differently. Altogether, these results suggest a biphasic effect of the drug treatment in the gut both on steroidogenesis and microbiota.â</p>
<p>Source:
Diviccaro, Silvia, et al. "Paroxetine effects in adult male rat colon: Focus on gut steroidogenesis and microbiota." Psychoneuroendocrinology (2022): 105828. https://doi.org/10.1016/j.psyneuen.2022.105828</p>
<p>Donations to University of Milan: https://www.gofundme.com/f/27l8qmes5c</p>
<p>In other news:</p>
<ul>
<li>(scientific paper, PSSD) Yacov Reisman, Tommaso B. Jannini, Emmanuele A. Jannini. Post-Selective Serotonin Reuptake Inhibitor Sexual Dysfunctions (PSSD): Clinical Experience with a Multimodal Approach. J. Mens. Health 2022, 18(8), 165. https://doi.org/10.31083/j.jomh1808165</li>
<li>(scientific paper, depression) Moncrieff, J., Cooper, R.E., Stockmann, T. et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01661-0</li>
<li>(scientific paper, PSSD) Achour, V., M. Masson, C. Lancon, L. Boyer, and G. Fond. 2022. âScreening and Treatment of Post-Selective Serotonin Reuptake Inhibitors Sexual Dysfunctions.â LâEncephale, August. https://doi.org/10.1016/j.encep.2022.07.001.</li>
<li>(media, PSSD) For Some People, the Sexual Side Effects of SSRIs Never Go Away</li>
</ul>
<p>Our website: postssrisyndrome.org</p>
<hr />
<h2 id="trovato-un-target-molecolare-in-comune-tra-paroxetina-e-finasteride-che-potrebbe-spiegare-le-disfunzioni-sessuali">Trovato un target molecolare in comune tra paroxetina e finasteride che potrebbe spiegare le disfunzioni sessuali</h2>
<p>Anche la paroxetina inibisce la PNMT, lâenzima responsabile della sintesi di adrenalina.</p>
<p>Questo lavoro multidisciplinare dell'unitÃ  di ricerca coordinata dal Prof. R.C. Melcangi dell'UniversitÃ  degli Studi di Milano sugli SSRI, Ã¨ stato pubblicato sulla rivista Journal of Molecular Structure. Link condivisibile con accesso e download libero al full text fino al 2 settembre: https://authors.elsevier.com/c/1fQ7v_WRZ2kK1).</p>
<p>Come Ã¨ stato possibile trovare un nuovo off-target di paroxetina per la prima volta dopo ben 30 anni dalla sua commercializzazione?</p>
<p>Ã stato utilizzato un approccio multidisciplinare. La prima fase ha coinvolto un metodo computazionale innovativo, sviluppato da un ricercatore italiano a Milano, in grado di cercare, su tutto il proteoma strutturale umano (decine di migliaia di proteine), potenziali siti di legame del farmaco oggetto di studio, in questo caso la paroxetina.</p>
<p>Ã importante sottolineare che questo screening in silico non aveva lo scopo di trovare bersagli in comune con finasteride, ma tutte le proteine (off-target, cioÃ¨ diverse dal trasportatore della serotonina) che potessero legarsi alla paroxetina per motivi squisitamente strutturali.</p>
<p>Tra i potenziali siti di legame restituiti dal software, tra i piÃ¹ probabili (in base alla loro struttura tridimensionale) Ã¨ stata trovata la feniletanolamina N-metiltransferasi (PNMT), l'enzima che converte noradrenalina in adrenalina (ultima tappa della biosintesi delle catecolamine), coinvolta in diversi processi biologici, tra cui l'erezione.</p>
<p>A questo punto, naturalmente, la cosa che ha colpito i ricercatori  Ã¨ stata che lo stesso off-target era stato in precedenza trovato (dagli stessi ricercatori: Giatti, Silvia, et al. "Three-dimensional proteome-wide scale screening for the 5-alpha reductase inhibitor finasteride: identification of a novel off-target." Journal of medicinal chemistry 64.8 (2021): 4553-4566) per la finasteride, farmaco associato a disfunzioni sessuali, sia durante, che dopo la sospensione del farmaco, (come ormai i foglietti illustrativi riportano). Quindi Ã¨ stato deciso di approfondire e verificare se effettivamente anche la paroxetina interagisce con l'enzima PNMT, come lo screening computazionale agnostico aveva suggerito.</p>
<p>Ulteriori analisi in silico, in questo caso il docking e la dinamica molecolare, hanno effettivamente confermato il risultato dello screening computazionale, nel senso che l'interazione farmaco-proteina sembrava effettivamente potersi realizzare senza problemi, peraltro nello stesso sito catalitico in cui si posiziona la noradrenalina per essere metilata e formare adrenalina. Questo fa pensare ad unâinibizione competitiva.</p>
<p>DopodichÃ© si Ã¨ passati ai saggi sperimentali, dapprima in vitro, e poi in vivo: il saggio in vitro ha effettivamente riscontrato un'inibizione parziale dell'enzima PNMT, mentre quello in vivo ha misurato un ridotto livello di adrenalina (il prodotto della PNMT, appunto) nella ghiandola surrenale.</p>
<p>Entrambi gli esperimenti in vitro e in vivo quindi hanno confermato e validato il risultato dello screening computazionale, ovvero una parziale inibizione dell'enzima PNMT da parte di paroxetina.</p>
<p>Dato che lâadrenalina interviene nel meccanismo dellâerezione, in antagonismo con la noradrenalina, questi risultati suggeriscono che la disfunzione sessuale indotta dalla paroxetina puÃ² essere dovuta, almeno in parte, all'inibizione della PNMT. Si deve anche tenere conto che non tutti hanno gli stessi livelli di espressione dell'enzima, quindi per alcuni una sua inibizione anche parziale potrebbe avere effetti molto gravi.</p>
<p>Sono necessari ulteriori studi per confermare che questa inibizione Ã¨ effettivamente causa o concausa della disfunzione erettile e per esplorare altri potenziali meccanismi con cui gli antidepressivi SSRI potrebbero indurre effetti collaterali sessuali, sia durante l'assunzione del farmaco, che dopo la sua sospensione.</p>
<p>Nel paper non viene discusso, ma questa inibizione potrebbe contribuire a spiegare anche altri effetti (emozionali, cognitivi, â¦?) della paroxetina, dato che lâadrenalina interviene in vari processi biologici.</p>
<p>Questo risultato Ã¨ importante non solo perchÃ© trova un nuovo off-target inatteso mai trovato prima e che potrebbe spiegare disfunzioni sessuali, ma anche perchÃ© conferma che ci sono meccanismi in comune tra SSRI e finasteride, come i ricercatori avevano precedentemente ipotizzato, dato che finasteride e paroxetina condividono uno stesso bersaglio enzimatico (PNMT). Questo Ã¨ un elemento inatteso che avvicina PSSD a PFS.</p>
<p>Per citare il paper:
Giatti, Silvia, et al. "Identification of a novel off-target of paroxetine: Possible role in sexual dysfunction induced by this SSRI antidepressant drug." Journal of Molecular Structure 1268 (2022): 133690</p>
<p>Altro studio dellâuniversitÃ  di Milano:</p>
<p>âI risultati ottenuti rivelano che la paroxetina influisce significativamente sui livelli di steroidi, solo nel colon ma non nel plasma. In particolare, le modificazioni degli steroidi osservate subito dopo il trattamento non sono sovrapponibili a quelle rilevate al momento della sospensione. Inoltre, il trattamento con paroxetina e la sua sospensione hanno un impatto diverso sulle popolazioni del microbiota intestinale. Complessivamente, questi risultati suggeriscono un effetto bifasico del trattamento farmacologico nell'intestino sia sulla steroidogenesi che sul microbiota.â</p>
<p>Fonte:</p>
<p>Diviccaro, Silvia, et al. "Paroxetine effects in adult male rat colon: Focus on gut steroidogenesis and microbiota." Psychoneuroendocrinology (2022): 105828. https://doi.org/10.1016/j.psyneuen.2022.105828</p>
<p>Donazioni allâUniversitÃ  di Milano: https://www.gofundme.com/f/27l8qmes5c</p>
<p>Altre news:</p>
<ul>
<li>(scientific paper, PSSD) Yacov Reisman, Tommaso B. Jannini, Emmanuele A. Jannini. Post-Selective Serotonin Reuptake Inhibitor Sexual Dysfunctions (PSSD): Clinical Experience with a Multimodal Approach. J. Mens. Health 2022, 18(8), 165. https://doi.org/10.31083/j.jomh1808165</li>
<li>(scientific paper, depression) Moncrieff, J., Cooper, R.E., Stockmann, T. et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01661-0</li>
<li>(scientific paper, PSSD) Achour, V., M. Masson, C. Lancon, L. Boyer, and G. Fond. 2022. âScreening and Treatment of Post-Selective Serotonin Reuptake Inhibitors Sexual * Dysfunctions.â LâEncephale, August. https://doi.org/10.1016/j.encep.2022.07.001.</li>
<li>(media, PSSD) For Some People, the Sexual Side Effects of SSRIs Never Go Away</li>
</ul>
<p>Il nostro sito: postssrisyndrome.org</p></div>
            </div>
        </div>

        <footer class="col-md-12">
            <hr>
            <p>Documentazione creata con <a href="https://www.mkdocs.org/">MkDocs</a>.</p>
        </footer>
        <script>
            var base_url = "../..",
                shortcuts = {"help": 191, "next": 78, "previous": 80, "search": 83};
        </script>
        <script src="../../js/base.js" defer></script>
        <script src="../../search/main.js" defer></script>

        <div class="modal" id="mkdocs_search_modal" tabindex="-1" role="dialog" aria-labelledby="searchModalLabel" aria-hidden="true">
    <div class="modal-dialog modal-lg">
        <div class="modal-content">
            <div class="modal-header">
                <h4 class="modal-title" id="searchModalLabel">Cerca</h4>
                <button type="button" class="close" data-dismiss="modal"><span aria-hidden="true">&times;</span><span class="sr-only">Chiudi</span></button>
            </div>
            <div class="modal-body">
                <p>Da qui puoi cercare questi documenti. Inserisci i termini di ricerca qui sotto.</p>
                <form>
                    <div class="form-group">
                        <input type="search" class="form-control" placeholder="Cerca..." id="mkdocs-search-query" title="Digita il termine di ricerca qui">
                    </div>
                </form>
                <div id="mkdocs-search-results" data-no-results-text="Nessun risultato trovato"></div>
            </div>
            <div class="modal-footer">
            </div>
        </div>
    </div>
</div><div class="modal" id="mkdocs_keyboard_modal" tabindex="-1" role="dialog" aria-labelledby="keyboardModalLabel" aria-hidden="true">
    <div class="modal-dialog">
        <div class="modal-content">
            <div class="modal-header">
                <h4 class="modal-title" id="keyboardModalLabel">Tastiera Rapida</h4>
                <button type="button" class="close" data-dismiss="modal"><span aria-hidden="true">&times;</span><span class="sr-only">Chiudi</span></button>
            </div>
            <div class="modal-body">
              <table class="table">
                <thead>
                  <tr>
                    <th style="width: 20%;">Chiavi</th>
                    <th>Azione</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td class="help shortcut"><kbd>?</kbd></td>
                    <td>Apri questa guida</td>
                  </tr>
                  <tr>
                    <td class="next shortcut"><kbd>n</kbd></td>
                    <td>Pagina successiva</td>
                  </tr>
                  <tr>
                    <td class="prev shortcut"><kbd>p</kbd></td>
                    <td>Pagina precedente</td>
                  </tr>
                  <tr>
                    <td class="search shortcut"><kbd>s</kbd></td>
                    <td>Cerca</td>
                  </tr>
                </tbody>
              </table>
            </div>
            <div class="modal-footer">
            </div>
        </div>
    </div>
</div>

    </body>
</html>
